Susquehanna International Group, LLP Biotechnology

Susquehanna International Group, LLP

$568 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NVO Novo Nordisk A S	$112B	$98.3 Million 0.02% of portfolio	1,414,913	Q1 2025 Added 395.23%
REGN Regeneron Pharmaceuticals, Inc.	$59.7B	$96.1 Million 0.02% of portfolio	151,458	Q1 2025 Added 84.27%
MDGL Madrigal Pharmaceuticals, Inc.	$6.14B	$47.2 Million 0.01% of portfolio	142,643	Q1 2025 Added 773.88%
RPRX Royalty Pharma PLC	$15.7B	$42.7 Million 0.01% of portfolio	1,371,626	Q1 2025 Reduced 33.76%
VKTX Viking Therapeutics, Inc.	$3.06B	$40.5 Million 0.01% of portfolio	1,676,804	Q1 2025 Added 62.26%
BPMC Blueprint Medicines Corp	$7.73B	$36.5 Million 0.01% of portfolio	412,540	Q1 2025 Added 202.87%
MRNA Moderna, Inc.	$10B	$34.8 Million 0.01% of portfolio	1,228,711	Q1 2025 Reduced 42.14%
INSM Insmed Inc	$16.5B	$34.2 Million 0.01% of portfolio	448,614	Q1 2025 Added 0.94%
SWTX Spring Works Therapeutics, Inc.	$2.93B	$27.5 Million 0.0% of portfolio	623,663	Q1 2025 Added 355.15%
TGTX Tg Therapeutics, Inc.	$3.94B	$26 Million 0.0% of portfolio	659,660	Q1 2025 Reduced 20.24%
BBIO Bridge Bio Pharma, Inc.	$7.28B	$25.6 Million 0.0% of portfolio	739,704	Q1 2025 Reduced 39.58%
CYTK Cytokinetics Inc	$3.23B	$21.7 Million 0.0% of portfolio	539,110	Q1 2025 Added 287.52%
VRTX Vertex Pharmaceuticals Inc	$99.5B	$19.9 Million 0.0% of portfolio	41,121	Q1 2025 Reduced 68.47%
ALNY Alnylam Pharmaceuticals, Inc.	$52.9B	$19 Million 0.0% of portfolio	70,465	Q1 2025 Added 551.43%
VCYT Veracyte, Inc.	$2.06B	$15.9 Million 0.0% of portfolio	536,404	Q1 2025 Added 999.41%
CORT Corcept Therapeutics Inc	$7.88B	$13.6 Million 0.0% of portfolio	119,230	Q1 2025 Added 224.58%
CNTA Centessa Pharmaceuticals PLC	$1.61B	$12.9 Million 0.0% of portfolio	899,505	Q1 2025 Added 5,612.59%
PCVX Vaxcyte, Inc.	$1.78B	$12 Million 0.0% of portfolio	318,338	Q1 2025 Added 153.87%
LQDA Liquidia Corp	$1.55B	$11.1 Million 0.0% of portfolio	750,787	Q1 2025 Added 116.58%
RXRX Recursion Pharmaceuticals, Inc.	$976M	$10.8 Million 0.0% of portfolio	2,049,611	Q1 2025 Added 22.95%
HALO Halozyme Therapeutics, Inc.	$8.95B	$10.4 Million 0.0% of portfolio	162,245	Q1 2025 Added 71.47%
JANX Janux Therapeutics, Inc.	$1.01B	$9.96 Million 0.0% of portfolio	368,935	Q1 2025 Added 1,151.86%
CRSP Crispr Therapeutics Ag	$4.42B	$9.9 Million 0.0% of portfolio	291,016	Q1 2025 Reduced 25.06%
PTGX Protagonist Therapeutics, Inc	$2.68B	$9.3 Million 0.0% of portfolio	192,239	Q1 2025 Added 174.87%
IMNM Immunome Inc.	$120M	$9.27 Million 0.0% of portfolio	1,377,053	Q1 2025 Added 1,567.24%
RVMD Revolution Medicines, Inc.	$3.09B	$8.63 Million 0.0% of portfolio	244,053	Q1 2025 Added 66.94%
CMRX Chimerix Inc	$748M	$8 Million 0.0% of portfolio	940,133	Q1 2025 Added 906.05%
MNKD Mannkind Corp	$942M	$7.54 Million 0.0% of portfolio	1,498,039	Q1 2025 Added 2.46%
AKRO Akero Therapeutics, Inc.	$2.23B	$7.3 Million 0.0% of portfolio	180,390	Q1 2025 Added 411.48%
ACAD Acadia Pharmaceuticals Inc	$4.12B	$7.07 Million 0.0% of portfolio	425,470	Q1 2025 Reduced 53.93%
AVXL Anavex Life Sciences Corp.	$840M	$6.75 Million 0.0% of portfolio	787,100	Q1 2025 Reduced 30.64%
BMRN Biomarin Pharmaceutical Inc	$10.6B	$6.47 Million 0.0% of portfolio	91,480	Q1 2025 Added 0.56%
ADMA Adma Biologics, Inc.	$3.29B	$6.11 Million 0.0% of portfolio	308,191	Q1 2025 Added 89.94%
KRYS Krystal Biotech, Inc.	$3.69B	$6.1 Million 0.0% of portfolio	33,829	Q1 2025 Reduced 12.06%
AXSM Axsome Therapeutics, Inc.	$4.51B	$6.03 Million 0.0% of portfolio	51,726	Q1 2025 Added 175.58%
IOVA Iovance Biotherapeutics, Inc.	$352M	$6 Million 0.0% of portfolio	1,802,193	Q1 2025 Reduced 32.32%
ETON Eton Pharmaceuticals, Inc.	$438M	$5.83 Million 0.0% of portfolio	448,804	Q1 2025 Added 133.36%
CPRX Catalyst Pharmaceuticals, Inc.	$2.09B	$5.72 Million 0.0% of portfolio	235,872	Q1 2025 Added 137.74%
RNA Avidity Biosciences, Inc.	$2.41B	$5.7 Million 0.0% of portfolio	193,063	Q1 2025 Added 157.79%
ARDX Ardelyx, Inc.	$866M	$5.42 Million 0.0% of portfolio	1,103,324	Q1 2025 Added 11.85%
PTCT Ptc Therapeutics, Inc.	$3.24B	$5.41 Million 0.0% of portfolio	106,067	Q1 2025 Added 4.33%
ALT Altimmune, Inc.	$177M	$5.38 Million 0.0% of portfolio	1,076,064	Q1 2025 Added 114.82%
ELDN Eledon Pharmaceuticals, Inc.	$36.6M	$5.38 Million 0.0% of portfolio	1,585,648	Q1 2025 Added 489.41%
AMLX Amylyx Pharmaceuticals, Inc.	$481M	$5.21 Million 0.0% of portfolio	1,470,925	Q1 2025 Added 69.39%
SRRK Scholar Rock Holding Corp	$1.66B	$5.17 Million 0.0% of portfolio	160,774	Q1 2025 Added 40.61%
SMMT Summit Therapeutics Inc.	$5.17B	$4.89 Million 0.0% of portfolio	253,499	Q1 2025 Added 228.26%
CRNX Crinetics Pharmaceuticals, Inc.	$1.53B	$4.63 Million 0.0% of portfolio	138,035	Q1 2025 Added 174.69%
RYTM Rhythm Pharmaceuticals, Inc.	$5.51B	$4.4 Million 0.0% of portfolio	82,980	Q1 2025 Added 63.78%
FOLD Amicus Therapeutics, Inc.	$1.96B	$4.38 Million 0.0% of portfolio	536,707	Q1 2025 Added 26.83%
RARE Ultragenyx Pharmaceutical Inc.	$1.97B	$4.36 Million 0.0% of portfolio	120,460	Q1 2025 Reduced 33.24%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.